000 | 01967 a2200529 4500 | ||
---|---|---|---|
005 | 20250513192449.0 | ||
264 | 0 | _c19991015 | |
008 | 199910s 0 0 eng d | ||
022 | _a1072-3714 | ||
024 | 7 |
_a10.1097/00042192-199906030-00008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPenotti, M | |
245 | 0 | 0 |
_aBlood flow in the internal carotid and middle cerebral arteries: effects of continuous oral conjugated equine estrogens administration with monthly progestogen supplementation on postmenopausal women. _h[electronic resource] |
260 |
_bMenopause (New York, N.Y.) _c1999 |
||
300 |
_a225-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
650 | 0 | 4 |
_aCarotid Artery, Internal _xdrug effects |
650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHormone Replacement Therapy _xmethods |
650 | 0 | 4 | _aHorses |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLinear Models |
650 | 0 | 4 |
_aMedrogestone _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPostmenopause _xdrug effects |
650 | 0 | 4 |
_aProgesterone Congeners _xadministration & dosage |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSironi, L | |
700 | 1 | _aCastiglioni, E | |
700 | 1 | _aMiglierina, L | |
700 | 1 | _aBarletta, L | |
700 | 1 | _aGabrielli, L | |
700 | 1 | _aVignali, M | |
773 | 0 |
_tMenopause (New York, N.Y.) _gvol. 6 _gno. 3 _gp. 225-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042192-199906030-00008 _zAvailable from publisher's website |
999 |
_c10444117 _d10444117 |